31 companies

Ascelia Pharma

Market Cap: SEK 294.1m

A biotech company, focuses on orphan oncology treatments in Sweden.

ACE

SEK 3.06

7D

-3.6%

1Y

-71.1%

Elicera Therapeutics

Market Cap: SEK 214.5m

A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.

ELIC

SEK 4.42

7D

30.4%

1Y

370.2%

Corline Biomedical

Market Cap: SEK 266.9m

Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications.

CLBIO

SEK 10.90

7D

21.4%

1Y

3.3%

Camurus

Market Cap: SEK 34.6b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, and internationally.

CAMX

SEK 590.00

7D

5.0%

1Y

18.4%

Bonesupport Holding

Market Cap: SEK 19.7b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

BONEX

SEK 299.00

7D

-3.9%

1Y

32.3%

Devyser Diagnostics

Market Cap: SEK 1.6b

Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.

DVYSR

SEK 95.00

7D

-5.0%

1Y

-3.8%

Xbrane Biopharma

Market Cap: SEK 299.2m

A biotechnology company, engages in the development, manufacture, and sale of biosimilars.

XBRANE

SEK 0.20

7D

6.1%

1Y

-9.8%

BioArctic

Market Cap: SEK 17.2b

Develops biological drugs for patients with disorders of the central nervous system in Sweden.

BIOA B

SEK 194.80

7D

9.9%

1Y

-0.1%

Newbury Pharmaceuticals

Market Cap: SEK 74.7m

Operates as hybrid pharmaceutical company in Sweden and the Scandinavian market.

NEWBRY

SEK 3.08

7D

-9.1%

1Y

-9.7%

Klaria Pharma Holding AB (publ.)

Market Cap: SEK 157.8m

Operates as a pharmaceutical company.

KLAR

SEK 1.09

7D

0%

1Y

190.7%

SenzaGen

Market Cap: SEK 165.8m

Provides non-animal tests for assessing a substance’s allergenicity.

SENZA

SEK 5.62

7D

10.6%

1Y

-19.7%

Egetis Therapeutics

Market Cap: SEK 1.4b

A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.

EGTX

SEK 3.77

7D

8.0%

1Y

-40.9%

BioInvent International

Market Cap: SEK 2.0b

A clinical-stage company, discovers, and develops novel immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.

BINV

SEK 30.90

7D

9.6%

1Y

18.8%

Active Biotech

Market Cap: SEK 104.8m

A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.

ACTI

SEK 0.085

7D

-5.3%

1Y

-84.8%

Hansa Biopharma

Market Cap: SEK 1.7b

A biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe.

HNSA

SEK 25.24

7D

12.2%

1Y

-12.8%

Moberg Pharma

Market Cap: SEK 359.5m

A pharmaceutical company, develops and commercializes medical products primarily in Sweden.

MOB

SEK 7.70

7D

-2.5%

1Y

-77.4%

Xspray Pharma

Market Cap: SEK 1.2b

A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.

XSPRAY

SEK 33.15

7D

-9.2%

1Y

-18.1%

Modus Therapeutics Holding

Market Cap: SEK 45.6m

A biotechnology company, develops a treatment for sepsis and septic shock in Sweden.

MODTX

SEK 1.27

7D

-0.8%

1Y

26.4%

AddLife

Market Cap: SEK 21.3b

Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries.

ALIF B

SEK 174.40

7D

13.8%

1Y

70.0%

Magle Chemoswed Holding

Market Cap: SEK 562.1m

Operates as a contract development and manufacturing organization that serves pharmaceutical and medical device industry on a contract basis in Sweden.

MAGLE

SEK 27.40

7D

-4.9%

1Y

-9.3%

BICO Group

Market Cap: SEK 2.6b

Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.

BICO

SEK 36.70

7D

1.8%

1Y

-20.7%

Swedencare

Market Cap: SEK 6.0b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.

SECARE

SEK 37.80

7D

5.1%

1Y

-33.2%

Biotage

Market Cap: SEK 11.3b

Provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing.

BIOT

SEK 140.80

7D

-0.1%

1Y

-16.2%

AlzeCure Pharma

Market Cap: SEK 210.1m

A pharmaceutical company, develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.

ALZCUR

SEK 2.38

7D

-1.7%

1Y

25.9%

FluoGuide

Market Cap: SEK 543.4m

A clinical stage biotechnology company, focuses on developing drugs for surgical outcomes by making cancer fluorescent in Denmark.

FLUO

SEK 39.90

7D

3.6%

1Y

-26.1%

Lipigon Pharmaceuticals

Market Cap: SEK 17.8m

Develops drugs for lipid related diseases in Sweden.

LPGO

SEK 0.12

7D

-0.4%

1Y

-64.7%

Vitrolife

Market Cap: SEK 20.4b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

VITR

SEK 150.40

7D

-1.4%

1Y

-9.6%

Cantargia

Market Cap: SEK 408.2m

A biotechnology company, develops antibody-based treatments for life threatening diseases.

CANTA

SEK 1.64

7D

4.9%

1Y

-50.8%

SynAct Pharma

Market Cap: SEK 947.8m

A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.

SYNACT

SEK 19.34

7D

4.7%

1Y

182.7%

BioGaia

Market Cap: SEK 10.1b

A healthcare company, provides probiotic products worldwide.

BIOG B

SEK 99.45

7D

-1.1%

1Y

-15.6%

Guard Therapeutics International

Market Cap: SEK 265.2m

A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.

GUARD

SEK 13.15

7D

1.9%

1Y

-55.0%